INHA and tuberculosis: Triclosan analogues (Freundlich et al, 2009; Vilcheze et al, 2011) and di-phenyl ether compounds (Sullivan et al, 2006) have been shown to inhibit InhA with nanomalar Ki and micromolar MICs and are both promising candidates as anti-tuberculosis compounds.